Marksans Pharma Ltd. specialises in the development, production, and marketing of pharmaceutical formulations for final dosages. The business uses best practises, automated manufacturing and packing processes, and the most recent technologies to guarantee the greatest quality healthcare.
To produce non-sterile liquids, ointments, and powder products, and has manufacturing and R&D facilities in Goa, India, and Southport, the UK. The business is present throughout the USA, Europe, South East Asia, Africa, Russia and the Commonwealth of Independent States, Latin America, and Australia.
Marksans Pharma Buyback Detail
|Issue Period||Jul 15, 2022 – Jan 14, 2023|
|Security Name||Marksans Pharma Ltd|
|Issue Type||Open Market Through Stock Exchange|
|Issue Size (Amount)||₹60.00 Crores|
|Buyback Price||₹60 per share|
|Face Value||₹1 per share|
|Listing At||BSE, NSE|
Summary of financial Information (Consolidated)
|Particulars||For the year/period ended (Rs. in Lakhs)|
|Profit After Tax||18,681.40||23,853.88||12,075.27|
|Reserves and Surplus||99,623.30||82,379.44||57,397.74|
Necessity of the Issue
The buyback is being undertaken for the following reasons:
1. The Buyback will help the Company to return surplus cash to its shareholders.
2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders’ value.
Marksans Pharma Buyback Documents
Company Contact Information
Marksans Pharma Ltd
Veera Desai Extension Road,
Oshiwara, Andheri (W), Mumbai – 400 053
Phone: +91 224001 2000
Marksans Pharma Buyback Registrar
- Bigshare Services Pvt Ltd
1st Floor, Bharat Tin Works Building,
Opp. Vasant Oasis,Makwana Road,
Marol, Andheri(E), Mumbai – 400 059
Phone: +91-22-6263 8200
Marksans Pharma Buyback Manager
- Sundae Capital Advisors